Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Amitriptyline for Repetitive Behaviors in Children and Adolescents With Autism Spectrum Disorders

NCT04725383 is registered in ClinicalTrials.gov with University of Missouri, Kansas City as lead sponsor.

NCT NCT04725383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04725383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Amitriptyline for Repetitive Behaviors in Children and Adolescents With Autism Spectrum Disorders
Lead sponsor
University of Missouri, Kansas City
Phase
Phase 3
Overall status
Terminated
Start date
November 1, 2023
Completion date
May 23, 2025
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder, repetitive compulsive behavior